Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Cancer Policy|May 7, 2025
Evaluation of treatment protocols based on the ESMO-magnitude of clinical benefit scale for gastrointestinal system cancers and their relationship with reimbursement policies in TurkeyOrhun Akdogan, Osman Sutcuoglu, Kadriye Bir Yucel, et al.
BMC Cancer|August 5, 2024
The impact of the expression level of growth differentiation factor 15 in tumor tissue on the response to immunotherapy in non-small cell lung cancerOrhun Akdogan, Betul Ogut, Osman Sutcuoglu, et al.
Endocrine-Related Cancer|August 28, 2024
Endocrine immune-related adverse events by immune checkpoint inhibitors and potential predictive markers: a prospective study from a single tertiary centerTugba Barlas, Osman Sutcuoglu, Orhun Akdogan, et al.
BMC Cancer|July 2, 2025
Evaluation of 30-day mortality rate following intravenous systemic anticancer therapy: a retrospective analysisTaha Enes Cetin, Osman Sutcuoglu, Orhun Akdogan, et al.
Clinical Rheumatology|February 2, 2021
Work productivity impairment in patients with familial Mediterranean fever and effects of interleukin-1 antagonistsErdem Suticen, Nuh Atas, Aslihan Avanoglu Guler, et al.
Cancers|January 8, 2025
Impact of Serum GDF-15 and IL-6 on Immunotherapy Response in Cancer: A Prospective StudyOrhun Akdogan, Sena Turkmen, Galip Can Uyar, et al.
European Journal of Cancer (Oxford, England : 1990)|April 11, 2025
Effect of a ChatGPT-based digital counseling intervention on anxiety and depression in patients with cancer: A prospective, randomized trialOrhun Akdogan, Galip Can Uyar, Enes Yesilbas, et al.
Cancer Investigation|December 26, 2025
Immunomodulatory Effect of First-Line Cisplatin Versus Carboplatin in Response to Second-Line Nivolumab Therapy in Metastatic Non-Small Cell Lung CancerOrhun Akdogan, Hatice Bolek, Kadriye Baskurt, et al.
Experimental Hematology & Oncology|June 9, 2026
Statins enhance trastuzumab deruxtecan efficacy: preclinical synergy in HER2-negative models and clinical benefit in HER2-positive metastatic breast cancerTaha Koray Sahin, Cemal Orhan, Ibrahim Hanifi Ozercan, et al.
Scientific Reports|October 16, 2025
Prognostic impact of hand-foot skin reaction in regorafenib-treated adult-type diffuse gliomas: A multicenter Turkish Oncology Group studySafa Can Efil, Burak Bilgin, Irem Bilgetekin, et al.
Pageof 2